Your browser doesn't support javascript.
loading
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.
O'Connor, Tracy; Zhou, Xiaolan; Kosla, Jan; Adili, Arlind; Garcia Beccaria, Maria; Kotsiliti, Elena; Pfister, Dominik; Johlke, Anna-Lena; Sinha, Ankit; Sankowski, Roman; Schick, Markus; Lewis, Richard; Dokalis, Nikolaos; Seubert, Bastian; Höchst, Bastian; Inverso, Donato; Heide, Danijela; Zhang, Wenlong; Weihrich, Petra; Manske, Katrin; Wohlleber, Dirk; Anton, Martina; Hoellein, Alexander; Seleznik, Gitta; Bremer, Juliane; Bleul, Sabine; Augustin, Hellmut G; Scherer, Florian; Koedel, Uwe; Weber, Achim; Protzer, Ulrike; Förster, Reinhold; Wirth, Thomas; Aguzzi, Adriano; Meissner, Felix; Prinz, Marco; Baumann, Bernd; Höpken, Uta E; Knolle, Percy A; von Baumgarten, Louisa; Keller, Ulrich; Heikenwalder, Mathias.
Afiliação
  • O'Connor T; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany; Division of Chronic Inflammation
  • Zhou X; Department of Neurology, Ludwig-Maximilians-University Hospital Munich, 81377 Munich, Germany; Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Kosla J; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Adili A; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany.
  • Garcia Beccaria M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Kotsiliti E; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Pfister D; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Johlke AL; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany.
  • Sinha A; Experimental Systems Immunology, Max Planck Institute of Biochemistry, Munich, Germany.
  • Sankowski R; Institute of Neuropathology, Medical Faculty, University of Freiburg, 79085 Freiburg, Germany.
  • Schick M; III. Medical Department, Technical University of Munich, 81675 Munich, Germany.
  • Lewis R; III. Medical Department, Technical University of Munich, 81675 Munich, Germany.
  • Dokalis N; Institute of Neuropathology, Medical Faculty, University of Freiburg, 79085 Freiburg, Germany.
  • Seubert B; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany.
  • Höchst B; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany.
  • Inverso D; Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), 69120 Heidelberg, Germany.
  • Heide D; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Zhang W; Department of Neurology, Ludwig-Maximilians-University Hospital Munich, 81377 Munich, Germany.
  • Weihrich P; Institute for Physiological Chemistry, University of Ulm, 89081 Ulm, Germany.
  • Manske K; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany.
  • Wohlleber D; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany.
  • Anton M; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany.
  • Hoellein A; III. Medical Department, Technical University of Munich, 81675 Munich, Germany.
  • Seleznik G; Institute of Neuropathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
  • Bremer J; Institute of Neuropathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
  • Bleul S; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert-Ludwigs University, 79106 Freiburg, Germany.
  • Augustin HG; Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), 69120 Heidelberg, Germany; European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Ge
  • Scherer F; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert-Ludwigs University, 79106 Freiburg, Germany.
  • Koedel U; Department of Neurology, Ludwig-Maximilians-University Hospital Munich, 81377 Munich, Germany.
  • Weber A; Department of Pathology and Molecular Pathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
  • Protzer U; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany.
  • Förster R; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • Wirth T; Institute for Physiological Chemistry, University of Ulm, 89081 Ulm, Germany.
  • Aguzzi A; Institute of Neuropathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
  • Meissner F; Experimental Systems Immunology, Max Planck Institute of Biochemistry, Munich, Germany.
  • Prinz M; Institute of Neuropathology, Medical Faculty, University of Freiburg, 79085 Freiburg, Germany; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany; Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germa
  • Baumann B; Institute for Physiological Chemistry, University of Ulm, 89081 Ulm, Germany.
  • Höpken UE; Max Delbrück Center for Molecular Medicine, 13092 Berlin, Germany.
  • Knolle PA; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany.
  • von Baumgarten L; Department of Neurology, Ludwig-Maximilians-University Hospital Munich, 81377 Munich, Germany.
  • Keller U; III. Medical Department, Technical University of Munich, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Hematology and Oncology, Charité - Universitätsmedizin Campus Benjamin Franklin, 12200 Berlin, Germany.
  • Heikenwalder M; Institute of Virology, Technical University of Munich, 81675 Munich, Germany; Helmholtz Center Munich, 85764 Neuherberg, Germany; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Ismaningerstraße 22, 81675 Munich, Germany; Division of Chronic Inflammation
Cancer Cell ; 36(3): 250-267.e9, 2019 09 16.
Article em En | MEDLINE | ID: mdl-31526758
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Neoplasias do Sistema Nervoso Central / Quimiocina CCL19 / Gliose / Linfoma Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Neoplasias do Sistema Nervoso Central / Quimiocina CCL19 / Gliose / Linfoma Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article